🔗 Share this article

This year's prestigious award in Physiology or Medicine was granted for revolutionary discoveries that illuminate how the immune system targets dangerous infections while sparing the healthy tissues.

Three esteemed researchers—Japan's Shimon Sakaguchi and American experts Dr. Brunkow and Fred Ramsdell—received this honor.

The research uncovered specialized "sentinels" within the defense system that eliminate malfunctioning defense cells capable of harming the organism.

The findings are now enabling innovative treatments for autoimmune diseases and malignancies.

The winners will share a prize fund worth 11m SEK.

Crucial Findings

"The work has been essential for comprehending how the body's defenses functions and the reason we do not all suffer from serious autoimmune diseases," stated the chair of the award panel.

The trio's studies address a fundamental mystery: How does the defense system defend us from numerous infections while leaving our healthy cells intact?

The body's protection system employs immune cells that search for signs of disease, including viruses and germs it has never encountered.

Such cells employ detectors—called receptors—that are produced by chance in a vast number of variations.

This gives the immune system the capacity to fight a broad range of threats, but the randomness of the mechanism unavoidably creates white blood cells that may target the host.

Protectors of the Immune System

Researchers previously understood that some of these harmful white blood cells were destroyed in the thymus—where white blood cells mature.

This year's award recognizes the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to neutralize any defenders that attack the healthy cells.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and rheumatoid arthritis.

A prize committee stated, "These findings have laid the foundation for a new field of research and spurred the creation of innovative therapies, for example for cancer and immune disorders."

In malignancies, T-regs block the system from fighting the tumor, so studies are aimed at reducing their quantity.

In autoimmune diseases, experiments are exploring increasing T-reg cells so the body is not being harmed. A comparable approach could also be useful in minimizing the risks of organ transplant rejection.

Innovative Studies

Professor Sakaguchi, of a Japanese institution, conducted experiments on rodents that had their thymus extracted, causing self-attack conditions.

He demonstrated that injecting immune cells from other mice could stop the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in rodents and people that resulted in the discovery of a gene critical for how T-regs operate.

"The pioneering work has revealed how the immune system is controlled by T-reg cells, stopping it from accidentally targeting the body's own tissues," said a prominent biological science specialist.

"The work is a striking example of how fundamental biological research can have broad implications for human health."